We monitored the increased disruption of blood brain barrier (BBB) by DCE-MRI at acute-stage of ischemic stroke in T2DM mice non-invasively. Furthermore, administration of novel P38 inhibitor is a promising way to promote BBB recovery in diabetic stroke and the therapeutic efficacy can be monitored by DCE-MRI.
This abstract and the presentation materials are available to members only; a login is required.